Skip to main content
Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc. — Investor Relations & Filings

Ticker · EBS ISIN · US29089Q1058 LEI · 549300YW6TUOX8BE5103 US Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2011-03-09 Director's Dealing
Country US United States of America
Listing US EBS

About Emergent BioSolutions Inc.

https://emergentbiosolutions.com/

Emergent BioSolutions Inc. is a life sciences company specializing in solutions for public health threats. The company develops, manufactures, and delivers medical countermeasures for national security and public health preparedness, addressing threats such as anthrax, smallpox, botulism, and Ebola. In addition to its biodefense portfolio, Emergent provides commercial products for endemic health crises, notably the opioid epidemic. The company also offers contract development and manufacturing services through strategic partnerships, leveraging its specialized capabilities to support biopharmaceutical innovators, governments, and non-governmental organizations.

Recent filings

Filing Released Lang Actions
3 Filing
Director's Dealing
2011-03-09 English
8-K Filing
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details executive compensation changes, including cash bonuses, base salaries, target bonus percentages, and equity awards (options and restricted stock units) granted to executives. This type of information relates to changes in senior management compensation and appointments. The key section is Item 5.02, which concerns departure or election of directors or officers and compensatory arrangements. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management and related compensation disclosures. The document is not a full annual report, audit report, or earnings release, nor is it a proxy statement or remuneration report (DEF 14A). It is a regulatory filing (Form 8-K) focused on management changes and compensation, so the best classification is MANG with high confidence.
2011-03-04 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the termination of a material definitive agreement between Emergent BioSolutions Inc. and East West Resources Corporation. There are no financial statements or detailed financial data included, only a description of the event and a letter agreement as an exhibit. The document length is 2465 characters, which is relatively short and consistent with a current report rather than a full financial report. This type of filing is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about a material event, not a full annual or quarterly report, audit report, or other specific category.
2011-02-23 English
SC 13G Filing
Major Shareholding Notification
2011-02-03 English
8-K/A Filing
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K/A, which is an amendment to a previously filed Form 8-K. It relates to the completion of an acquisition and includes financial statements and pro forma financial information related to the acquisition of Trubion Pharmaceuticals, Inc. The document contains detailed financial data and pro forma combined financial statements, which are typical for acquisition-related filings. The presence of financial statements and pro forma information indicates this is not just an announcement but includes substantive financial data. Given the content and the nature of the filing, this fits best under the category of Capital/Financing Update (CAP), as it updates on company financing activities and acquisition completion with financial details. It is not a full Annual Report (10-K), nor a simple announcement (RPA), nor a merger proxy statement (MA). Therefore, the classification is CAP with high confidence.
2011-01-13 English
SC 13G/A Filing
Major Shareholding Notification
2011-01-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.